(Q36669637)

English

Sunitinib

scientific article published on January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

Sunitinib (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Gillian M Keating

2

object named as

Gillian M Keating

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1

object named as

Emma D Deeks

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

2255-66; discussion 2267-8

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Rhebbing up mTOR: New Insights on TSC1 and TSC2, and the Pathogenesis of Tuberous Sclerosis

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666170-00007

21 January 2018

Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors.

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666170-00007

21 January 2018

Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17137406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17137406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17137406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17137406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biology of gastrointestinal stromal tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17137406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel agents for the treatment of advanced kidney cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17137406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/17137406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sunitinib in patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17137406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17137406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/17137406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17137406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17137406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17137406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200666170-00007

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Dimensions Publication ID

0 references

release_cia3ln3klnac5kuijvob6q7hpq

1 reference

https://api.fatcat.wiki/v0/release/cia3ln3klnac5kuijvob6q7hpq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36669637&oldid=2199161051"